Jones Trading analyst Soumit Roy downgraded ESSA Pharma (NASDAQ: EPIX) from Buy to Hold.The analyst comments "Summary: Futility analysis showed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE